Do I qualify for GLP-1 medication if I only need to lose 20 pounds?

Short answer: maybe — it depends mainly on your BMI and any weight-related health conditions. GLP-1 medications for weight loss are usually prescribed when a person meets clinical/insurance criteria, and a prescriber must evaluate you first.

Key rules and what they mean for you

• FDA-labeled indications (most insurers follow these)
  • Chronic weight management (Wegovy [semaglutide] and Zepbound [tirzepatide]): typically for people with BMI ≥30, or BMI ≥27 plus at least one weight-related comorbidity (high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea, etc.).
  • Diabetes indications (Ozempic [semaglutide], Mounjaro [tirzepatide], etc.): dosing/coverage differ; these are approved for glycemic control and often improve weight.
• If you only need to lose about 20 pounds, whether you “qualify” depends on your current height and weight (your BMI). Example: a person 5'6" (66 in)
  • 180 lb → BMI ≈ 29.0 (may not meet BMI ≥30)
  • 180 lb minus 20 lb → 160 lb → BMI ≈ 25.8 If your starting BMI is below 30 and you don’t have qualifying comorbidities (BMI <27), most insurers and many clinicians won’t approve the branded weight-loss GLP-1s.
• Some clinicians will prescribe off-label to people with lower BMIs, but that varies widely and often is out-of-pocket (costly).

Safety and contraindications (things prescribers will check)

• Don’t use if you have personal/family history of medullary thyroid carcinoma or MEN2, are pregnant or planning pregnancy, or have certain pancreatic/GI conditions. Common side effects include nausea, vomiting, constipation, and occasional low blood sugar if used with insulin or sulfonylureas.

Which drugs/services you might encounter (brand names)

• Wegovy (semaglutide) — FDA-approved for chronic weight management; the standard branded option for obesity treatment.
• Zepbound (tirzepatide) — FDA-approved for chronic weight management; very effective in trials for larger weight loss.
• Ozempic (semaglutide) and Mounjaro (tirzepatide) — approved for type 2 diabetes; sometimes used off-label for weight loss.
• If cost/coverage is an issue, check GoodRx or speak to your pharmacist about patient-assistance programs.

What to do next (practical steps)

1. Calculate your BMI: BMI = (weight in pounds / height in inches^2) × 703. Or tell me your height and weight and I can calculate it for you.
2. See your primary care doctor or an endocrinologist/weight-management clinic to discuss goals, medical history, and whether a GLP-1 is appropriate. Clinics/telehealth that offer weight-medication evaluation include One Medical, PlushCare, Ro, and Hims & Hers — but I recommend starting with your PCP.
3. Ask your insurer about coverage criteria (BMI + comorbidity requirements) and preauthorization rules.
4. If you don’t qualify or prefer not to use medication, discuss lifestyle programs, behavioral therapy, or other medications (e.g., orlistat/Xenical) and, if appropriate, surgical options.

If you want, tell me your height and current weight and I’ll calculate your BMI and say whether you’d hit the usual eligibility thresholds.